Bright Green Corp. (Nasdaq: BGXX) recently published a letter from its chief executive officer, Gurvinder Singh, telling investors of its lofty goals and strategy of accepting foreign investor money through an EB-5 program, the employment-based fifth preference visa participants receive. According to the U.S. Citizenship and Immigration Services, an investor …
Category: Psychedelics
ICER report rebukes Lykos’ MDMA-AP study
The Institute for Clinical and Economic Review (ICER) recently posted its revised evidence report assessing the comparative clinical effectiveness and value of 3,4-Methylenedioxymethamphetamine-assisted psychotherapy (MDMA-AP, a psychotherapy protocol from Lykos Therapeutics) for the treatment of post-traumatic stress disorder (PTSD). ICER provides independent evaluations of medical tests, treatments, and systems. The …
Critics of Lykos’ MDMA trials come out in force at meeting as FDA committee denies approval request
A panel of independent health advisers convened Tuesday to consider a landmark proposal to approve MDMA as a treatment for post-traumatic stress disorder. In the end, Lykos’ MDMA drug approval proposal to treat PTSD failed with a 1-10 vote, reducing the chance for federal approval later this summer. The Psychopharmacologic …
The Daily Hit: June 3, 2024
The Daily Hit is a recap of the top financial news stories for Monday, June 3, 2024. On the Site Rescheduling, 280E tax reform, and Trulieve: How the cannabis industry could be poised to save billions Although it’s now widely accepted that the ongoing marijuana rescheduling process by the Drug …